(Information sent by the signatory company)
HORSHAM, Pa., May 2, 2024 /PRNewswire/ — Myonex has completed the previously announced acquisition of CREAPHARM’s pharmaceutical services business. This transaction combines capabilities and flexibility to serve both clinical and commercial stage pharmaceutical and biotechnology companies, including companies managing Advanced Therapies. Creapharm’s clinical packaging and distribution services, commercial packaging operations and bioservices will now be known as Creapharm, a Myonex company.
“We are delighted to have completed the acquisition of Creapharm, a milestone that expands our services and enhances our capabilities for clients and the industry. Together, we are prepared to meet the dynamic needs of our clients with agility, flexibility and reliability,” said James Lovett, CEO of Myonex.
“We are excited to welcome Eric Placet, the visionary founder and former CEO of CREAPHARM, to the Myonex board of directors. His decision to reinvest in the company is a testament to our shared commitment to excellence and innovation. Additionally “We are pleased to announce the appointment of Carla Da Costa as our Chief Operating Officer, further strengthening our executive team as we continue to drive growth and deliver exceptional value to our customers,” said Mike Cohen, CEO of Myonex. Edouard Placet will continue in his role as Director of Strategic Development at Myonex.
Myonex was advised by McDermott, Will
About Myonex
Myonex is a leading global full clinical trial supply company, offering customized solutions in drug sourcing, packaging, labeling and supply of central and local equipment and accessories to support the specific requirements and complexities of each trial. With locations in the US, Germany and the UK, we partner with pharmaceutical and biotechnology companies, contract research organizations (CROs), and other clinical trial service providers seeking a flexible, comprehensive solution for their clinical trials needs. essay supply. Learn more at www.myonex.com
About Creapharm With decades of experience in global clinical trial supply management, Creapharm supports key players in the pharmaceutical and biotechnology industry with customized solutions. Creapharm has strong experience in cold chain management and has recently developed ultra-cold solutions for handling biologics and ATMP supply chain management. For marketed healthcare products, Creapharm offers expert commercial packaging services to the pharmaceutical and dietary supplement industries. Learn more at www.creapharm-pharma.com.
CONTACT: Maryanne Walsh(1) 267-307-0876
Logo – https://mma.prnewswire.com/media/2381955…
View original content: https://www.prnewswire.com/news-releases/myonex-cierra-la-adquisicion-de-creapharm-ampliando-los-servicios-globales-302134667.html
